… We aimed to find out whether the incidence of cervical abnormalities detected by screening
has changed since the introduction of the HPV vaccination programme in April, 2007, …

… HPV vaccination substantially reduced cervical abnormalities for women receiving any
HPV vaccine dose through a school-based program, within five years of implementation. …

… of cervical lesions before and after implementation of nationwide HPV vaccination programs
… in all age groups before implementation of HPV vaccination, especially during 2005–2010. …

… HPV vaccination on cervical abnormalities and cancer incidence while accounting for all
known high-risk HPV … parameters for HPV transmission and development of precursor lesions, …

… Mathematical models of the impact of HPV vaccines have also … vaccines to prevent
cervical lesions caused by the target HPV types that are responsible for the majority of cervical …

… for human papillomavirus (HPV) vaccination has been suspended since June 2013. In this
study, we examined vaccination rate and incidence of abnormal cervical cytology in women …

… Despite its much greater accuracy and efficiency in detecting existing high-grade cervical
lesions, the HPV/Pap triage paradigm has not yet been adopted for primary screening because …

… A triage test will be required to distinguish hrHPV-positive (nonvaccinated and vaccinated)
women with clinically relevant cervical lesions from those with transient infections. The S5 …

… is consistent with previous findings that showed a lower risk of genital warts and high-grade
cervical lesions with HPV vaccination. Our results also support the recommendation to …

… The low-risk (LR) HPV types 6 and 11 are mainly associated with low-grade cervical lesions
… coverage of an HPV 16/18 vaccine, our results suggest that the vaccine could prevent at …